Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream

Journal of the American Academy of Dermatology
Oliverio WelshBrian Berman

Abstract

Ten patients with superficial infantile hemangiomas were treated with imiquimod 5% cream for up to 16 weeks. Four patients achieved complete clinical resolution, 3 had excellent improvement, one showed moderate improvement, and one patient did not respond to therapy. Imiquimod may be an effective alternative for the treatment of superficial hemangiomas.

References

Dec 10, 1999·The Journal of Pediatrics·J DuboisM David
Jun 29, 2002·International Journal of Dermatology·Mario Marini
Jun 29, 2002·International Journal of Dermatology·Richard Miller
Jan 8, 2004·The Journal of Investigative Dermatology·Robert SidburyAmy S Paller

❮ Previous
Next ❯

Citations

Mar 5, 2013·Paediatric Drugs·Brittany G Craiglow, Richard J Antaya
May 27, 2005·Pediatric Dermatology·Paul G HazenArrthapol Tanphaichitr
Jan 19, 2006·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Rafael F Martin-García, Ana C Busquets
Feb 7, 2012·Journal of the American Academy of Dermatology·Jennifer K ChenMichal Heger
Jan 17, 2012·Journal of the American Academy of Dermatology·Anne Marie TremaineKristen M Kelly
Sep 1, 2010·Surgical Pathology Clinics·Paula E North
Nov 21, 2009·Journal of the American Academy of Dermatology·Vivian LaquerKristen M Kelly
Dec 28, 2006·Journal of the American Academy of Dermatology·Nhung T C HoElena Pope
Nov 23, 2006·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Paula E NorthMartin C Mihm
May 20, 2008·Clinical and Experimental Dermatology·R B M BarryL J Cook
Sep 15, 2007·The British Journal of Dermatology·D J KoubaR L Moy
Nov 20, 2012·Oncoimmunology·Erika VacchelliGuido Kroemer
Jul 9, 2016·International Journal of Dermatology·Edith HannaOssama Abbas
Aug 3, 2010·Anais Brasileiros De Dermatologia·Adriana Maria da Silva SerraIzelda Maria Carvalho Costa
Nov 30, 2007·Expert Reviews in Molecular Medicine·Matthew R RitterSheila F Friedlander
Mar 12, 2008·Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology·Beatriz Fernández JorgeEduardo Fonseca
Mar 23, 2020·The Journal of Dermatology·Hidefumi MimuraSatoru Sasaki
Sep 21, 2005·Archives of Facial Plastic Surgery·Roy F ThomasJonathan A Perkins
Sep 8, 2007·Dermatology : International Journal for Clinical and Investigative Dermatology·Gulsum GencoglanBanu Ertekin
May 26, 2018·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Shari R Lipner
Mar 25, 2020·Japanese Journal of Radiology·Hidefumi MimuraSatoru Sasaki
Mar 24, 2020·Pediatrics International : Official Journal of the Japan Pediatric Society·Hidefumi MimuraSatoru Sasaki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Microcirculation : the Official Journal of the Microcirculatory Society, Inc
M J RazonJoyce Bischoff
Proceedings of the National Academy of Sciences of the United States of America
Matthew R RitterMartin Friedlander
© 2021 Meta ULC. All rights reserved